Your browser doesn't support javascript.
loading
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
Metheny, Leland; Callander, Natalie S; Hall, Aric C; Zhang, Mei-Jei; Bo-Subait, Khalid; Wang, Hai-Lin; Agrawal, Vaibhav; Al-Homsi, A Samer; Assal, Amer; Bacher, Ulrike; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Chris; Byrne, Michael; Cairo, Mitchell; Cerny, Jan; DeFilipp, Zachariah; Perez, Miguel Angel Diaz; Freytes, César O; Ganguly, Siddhartha; Grunwald, Michael R; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Inamoto, Yoshihiro; Kanakry, Christopher G; Kharfan-Dabaja, Mohamed A; Lazarus, Hillard M; Lee, Jong Wook; Nathan, Sunita; Nishihori, Taiga; Olsson, Richard F; Ringdén, Olov; Rizzieri, David; Savani, Bipin N; Savoie, Mary Lynn; Seo, Sachiko; van der Poel, Marjolein; Verdonck, Leo F; Wagner, John L; Yared, Jean A; Hourigan, Christopher S; Kebriaei, Partow; Litzow, Mark; Sandmaier, Brenda M; Saber, Wael; Weisdorf, Daniel; de Lima, Marcos.
Affiliation
  • Metheny L; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Electronic address: Leland.metheny@uhhospitals.org.
  • Callander NS; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Hall AC; University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Zhang MJ; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bo-Subait K; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Wang HL; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Agrawal V; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Al-Homsi AS; New York University Langone Health, New York, New York.
  • Assal A; Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, New York.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.
  • Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Minneapolis, Minnesota.
  • Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
  • Bredeson C; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Byrne M; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Cairo M; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
  • DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts.
  • Perez MAD; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Freytes CO; University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhavi, United Arab Emirates.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Kanakry CG; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Lee JW; Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida.
  • Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Ringdén O; Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention, and Technology) Karolinska Institutet, Stockholm Sweden.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Savoie ML; University of Calgary, Calgary, Alberta, Canada.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • van der Poel M; Maastricht University Medical Center, Maastricht, The Netherlands.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
  • Wagner JL; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
  • Hourigan CS; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Kebriaei P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Litzow M; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Sandmaier BM; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Saber W; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • de Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
Transplant Cell Ther ; 27(11): 923.e1-923.e12, 2021 11.
Article de En | MEDLINE | ID: mdl-34428556

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndromes myélodysplasiques / Leucémie aigüe myéloïde Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Middle aged Langue: En Journal: Transplant Cell Ther Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndromes myélodysplasiques / Leucémie aigüe myéloïde Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Middle aged Langue: En Journal: Transplant Cell Ther Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique